ADUS — Addus HomeCare Corporation stock price and chart

ADUS

$118.03+2.49%

as of close, Oct 20, 2026

☾ AH $118.03 +2.49%

Addus HomeCare CorporationStock · HealthcareRussell 2000 · 0.06% of IWMNasdaq Composite · 0.006% of ONEQUS Stock Market · 0.002% of VTIRussell 3000 · 0.002% of IWV

PeersENSGUHSEHCSPYQQQNVDA

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeEEEEEEEEEEEE

20162019202120242026

30.040.050.060.070.080.090.0100.0110.0120.0130.002.0M4.0M$118.03

2026-10-20

Price$118.03

MA20$109.00

MA50$109.10

Vol578.6K

What would $1,000 invested in ADUS be worth today? →

ADUS returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $118.03
YTD price return: +9.91%
YTD total return: +9.91%
Next earnings: Nov 3, 2026 · After close
Market cap: 2.2B2016-12 401.8M2026-10 2.2B+448.6% over the window
Enterprise value: 2.2B
Shares outstanding: 18.7M2016-06 11.5M2026-06 18.7M+62.9% over the window
52W low: $87.95
52W high: $124.44
From 52W high: -5.15%
From 52W low: +34.20%
52W range: 82%

Volume

Rel volume: 0.69×
30D volume: 201.1K
30D $ vol: 23.1M

Fundamentals

Sales (ttm): 1.5B2016-12 400.9M2026-06 1.5B+268.2% over the window
Sales/share: $79.062016-12 $34.772026-06 $79.06+127.4% over the window
EPS (ttm): $5.712016-06 $0.792026-06 $5.71+622.3% over the window
FCF (ttm): 154.8M2016-06 -51.4M2026-06 154.8M-401.3% over the window
FCF/share: $8.292016-06 -$4.482026-06 $8.29-285.0% over the window
Book value/share: $61.482016-06 $12.942026-06 $61.48+375.2% over the window
Net margin: 7.13%2016-12 3.0%2026-06 7.1%+135.2% over the window
ROE: 9.17%2016-06 6.0%2026-06 9.2%+51.7% over the window
ROA: 7.23%2016-06 3.7%2026-06 7.2%+95.9% over the window
Debt / equity: 0.05×2016-06 0.272026-06 0.05-80.2% over the window
Current ratio: 1.692016-06 2.992026-06 1.69-43.6% over the window

Growth (CAGR, ttm) · 10Y

Sales: +15.89%2025-06-30 → 2026-06-301.3B → 1.5B (+15.9% total)+13.90%2023-06-30 → 2026-06-30999.1M → 1.5B (+47.8% total)+12.67%2021-06-30 → 2026-06-30813.2M → 1.5B (+81.6% total)+14.72%2016-12-31 → 2026-06-30400.9M → 1.5B (+268.2% total)
Net income: +26.94%2025-06-30 → 2026-06-3083M → 105.3M (+26.9% total)+25.06%2023-06-30 → 2026-06-3053.8M → 105.3M (+95.6% total)+22.58%2021-06-30 → 2026-06-3038.1M → 105.3M (+176.7% total)+27.94%2016-06-30 → 2026-06-309M → 105.3M (+1074.6% total)
FCF: +65.31%2025-06-30 → 2026-06-3093.7M → 154.8M (+65.3% total)+17.88%2023-06-30 → 2026-06-3094.5M → 154.8M (+63.8% total)+24.69%2021-06-30 → 2026-06-3051.4M → 154.8M (+201.3% total)n/a
Shares: +1.45%2025-06-30 → 2026-06-3018.4M → 18.7M (+1.5% total)+4.82%2023-06-30 → 2026-06-3016.2M → 18.7M (+15.2% total)+3.25%2021-06-30 → 2026-06-3015.9M → 18.7M (+17.3% total)+5.00%2016-06-30 → 2026-06-3011.5M → 18.7M (+62.9% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +25.92%2025-06-30 → 2026-06-30$4.53 → $5.71 (+25.9% total)+19.90%2023-06-30 → 2026-06-30$3.31 → $5.71 (+72.4% total)+19.22%2021-06-30 → 2026-06-30$2.37 → $5.71 (+140.8% total)+21.87%2016-06-30 → 2026-06-30$0.79 → $5.71 (+622.3% total)
Sales/share: +14.23%2025-06-30 → 2026-06-30$69.22 → $79.06 (+14.2% total)+8.66%2023-06-30 → 2026-06-30$61.62 → $79.06 (+28.3% total)+9.13%2021-06-30 → 2026-06-30$51.09 → $79.06 (+54.8% total)+9.04%2016-12-31 → 2026-06-30$34.77 → $79.06 (+127.4% total)
FCF/share: +62.95%2025-06-30 → 2026-06-30$5.09 → $8.29 (+62.9% total)+12.46%2023-06-30 → 2026-06-30$5.83 → $8.29 (+42.2% total)+20.76%2021-06-30 → 2026-06-30$3.23 → $8.29 (+156.8% total)n/a
Book value/share: +10.76%2025-06-30 → 2026-06-30$55.51 → $61.48 (+10.8% total)+14.37%2023-06-30 → 2026-06-30$41.10 → $61.48 (+49.6% total)+12.46%2021-06-30 → 2026-06-30$34.18 → $61.48 (+79.9% total)+16.87%2016-06-30 → 2026-06-30$12.94 → $61.48 (+375.2% total)
Price: -2.79%2025-10-20 → 2026-10-20$121.42 → $118.03 (-2.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+13.40%2023-10-20 → 2026-10-20$80.94 → $118.03 (+45.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+8.53%2021-10-20 → 2026-10-20$78.39 → $118.03 (+50.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+15.87%2016-10-19 → 2026-10-20$27.06 → $118.03 (+336.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: -2.79%2025-10-20 → 2026-10-20$121.42 → $118.03 (-2.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+13.40%2023-10-20 → 2026-10-20$80.94 → $118.03 (+45.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+8.53%2021-10-20 → 2026-10-20$78.39 → $118.03 (+50.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+15.87%2016-10-19 → 2026-10-20$27.06 → $118.03 (+336.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 20.7×2016-12 51.662026-10 20.93-59.5% over the window
P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.: 14.9×2016-12 38.062026-10 14.87-60.9% over the window
Fwd P/E: 15.4×
P/S (ttm)Market cap ÷ TTM revenue.: 1.5×2017-03 0.932026-10 1.49+61.2% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 1.9×2016-12 2.672026-10 1.92-28.1% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 14.2×2016-12 16.572026-10 14.24-14.1% over the window
EV/EBITDA (fy): 13.4×
EV/Sales (ttm): 1.5×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 7.02%2016-09 6.0%2026-06 8.2%+36.7% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 18.7M ÷ 18.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: -1.45%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.45%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($2.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: -1.45%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($2.2B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 0.00%2016-09 0.0%2026-06 0.0%
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($2.2B). Same caveat as the cash buyback yield.: 0.00%2016-09 0.0%2026-06 0.0%

Vs own 10Y history

P/E: 7th
P/OI: 8th
P/S: 33rd
P/B: 9th
P/FCF: 19th

Bar = where today’s multiple sits in ADUS’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+2.49%

+3.06%

+0.82%

+5.86%

YTD

+9.91%

-2.79%

+50.57%

Financial statements

Open full ADUS financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

ADUS — Addus HomeCare Corporation price, chart and key statistics